Publicly Traded Cannabis Stock News
In a recent interview, Canadian licensed medical cannabis producer Aphria (TSX Venture: APH) CEO Vic Neufeld discussed that wholesaling to other licensed producers (LPs) accounted for about 20-25% of...
Research analyst Derik De Bruin, who has been at Bank of America Merrill Lynch as its lead analyst for the Life Sciences Tools and Diagnostics sector since 2011 following...
CEO Daniel Yazbeck of MyDx Inc. (OTC: MYDX) interviews with David Friedman, CEO of MJIC Media, LLC at the Cannabis Growth Capital Conference in Las Vegas, NV in November....
GW Pharmaceuticals (NASDAQ: GWPH) reported its fiscal year-end results today and held a conference call after the market closed. One of the more interesting parts of the prepared remarks involved...
Pharmaceutical CBD (cannabidiol) Shows Promise for Children with Severe Epilepsy Significant seizure reduction in studies using CBD in combination with AEDs PHILADELPHIA, December 7, 2015 – Around the globe...
After the market close, Supreme Pharma announced that it will receive its pre-license inspection on December. The company, along with several others, has been waiting all year for an...
We publish a lot of content on the Canadian cannabis industry at New Cannabis Ventures. 15% of our visitors reside in Canada, perhaps consequently, and I spend a great deal of...
Director Kim McNicholas shared the news today regarding the semi-finalists in Extreme Tech Challenge, as the field narrowed from 25 to 10. Cannabis social network company MassRoots (OTC:MSRT) advanced....
Each month, Alan Brochstein of 420 Investor publishes a comprehensive review of the publicly traded cannabis-related stocks and discusses several key topics. The October edition included: Market Review and Outlook...
After failing to close its previously announced transaction to sell itself to Abba Medix (CSE:ABA), RedeCan Pharm, which is licensed by Health Canada under MMPR to sell cannabis grown...
The Albany Times Union has reported that Vireo Health of New York, formerly Empire State Health Solutions, will use the Captisol technology that it has licensed from Ligand Pharmaceuticals...
More than nine months after receiving its license to cultivate, Aurora Cannabis, which has the sole licensed facility in Alberta, has finally received approval to sell to patients according to...
The Denver Post was able to shed additional light on the story that we broke on Tuesday regarding cannabis testing company CannLabs closing its Colorado facility. The CEO appeared to...
While there are high expectations that Canada will adopt legal cannabis for adult use, it is unclear how the program will develop. On its Q2 conference call today, Canopy...
Vireo Health Seeks to Develop FDA Approved Cannabinoid-Based Medications Medical cannabis company with operations in New York and Minnesota signs exclusive Captisol® licensing and supply agreements with Ligand Pharmaceuticals ALBANY,...
Canopy Growth Corporation Maintains Revenue Momentum with 44% Increase in Q2 over Q1 of Fiscal 2016 SMITHS FALLS, ON, Nov. 26, 2015 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or...
This next week will be a big one for GW Pharmaceuticals (NASDAQ: GWPH). In addition to presenting at the Piper Jaffray Healthcare Conference in NYC on Wednesday, it will...
Ligand Pharmaceuticals (NASDAQ: LGND) has issued an 8-K with the SEC this morning detailing a licensing and supply agreement with Vireo Health, which is licensed in Minnesota and New York...
Following up on yesterday’s report that CannLabs had closed its Colorado testing lab, we note that the company has filed a brief statement with the SEC via Form 8-K: On...
We are hearing that testing lab CannLabs has closed its sole facility at 3888 E. Mexico in Denver, Colorado. According to our sources, all of the employees have been...
Bloomberg has put together a beautiful photo essay of Canopy Growth’s Tweed factory in Smith Falls, Ontario. The picture above, which captures the trimming process, is just one of...
CNET just published a series of articles on the cannabis industry, the third of which looks at several of the efforts aimed at using technology to take advantage of...
GW Pharma (GWPH) plunged today before quickly recovering some of the losses following the release of an abstract of a study published to the American Epilepsy Society website in...
Aphria (TSX Venture: APH) issued a press release after the close today indicating a large capital raise. The stock had been halted in advance with an hour of...
Surna (OTC:SRNA), the Boulder-based cannabis technology company, saw explosive growth in its Q3, with sales of $3.6mm. While the company reported an operating and net loss, it was able...
